Dr Larry David Bomsta, MD | |
467 Washington St, Montpelier, ID 83254-1544 | |
(208) 847-0072 | |
(208) 847-0077 |
Full Name | Dr Larry David Bomsta |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 467 Washington St, Montpelier, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114086048 | NPI | - | NPPES |
5549-1 | Other | ID | BLUE CROSS OF IDAHO |
000010004905 | Other | ID | BLUE SHIELD OF IDAHO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 5549 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Larry David Bomsta, MD 467 Washington St, Montpelier, ID 83254-1544 Ph: (208) 847-0072 | Dr Larry David Bomsta, MD 467 Washington St, Montpelier, ID 83254-1544 Ph: (208) 847-0072 |
News Archive
What does it mean for expectant mothers and hospitals when there are large-scale closures of maternity units? A new study led by researchers at The Children's Hospital of Philadelphia provides an inside view from hospital staff members in Philadelphia, where 13 out of 19 obstetric units closed in a 15-year period.
An international team of researchers from the CEA, the CNRS, the Institut Laue-Langevin, the Jülich Centre for Neutron Science, the University of California Irvine, the Australian Institute of Science and Technology Organisation, the Max Planck Institute Mülheim and the University of Perugia has shed light on the molecular mechanism behind the importance of water for functional protein dynamics.
The University of Illinois at Chicago College of Pharmacy has received a grant from the U.S. Department of Defense to develop new drugs to combat agents of bioterrorism.
On 1 September 2009, Unilife Medical Solutions Limited (ASX: UNI) (PINKSHEETS: UNIFF) (Unilife Australia) entered into a Merger Implementation Agreement with Unilife Corporation (Unilife USA) to facilitate the proposed redomiciliation of the Unilife group in the United States of America (Proposed Transaction).
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
› Verified 3 days ago
Trevor Dean Jacobson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 166 S 5th St, Montpelier, ID 83254 Phone: 208-847-1110 Fax: 208-847-0228 | |
Noall E Wolff, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 360 N 2nd St, Montpelier, ID 83254 Phone: 208-847-5834 | |
Houston Reynolds, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 164 S 5th St, Montpelier, ID 83254 Phone: 208-514-2529 | |
Lance A Hansen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 465 Washington St, Montpelier, ID 83254 Phone: 208-847-4495 Fax: 208-847-4336 | |
Dr. Peter Melvin Crane, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 465 Washington St, Montpelier, ID 83254 Phone: 208-847-4495 | |
Clay I. Campbell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 166 So 5th St, Montpelier, ID 83254 Phone: 208-847-3847 Fax: 208-847-1620 |